TD Cowen Initiates HCA Healthcare(HCA.US) With Buy Rating, Announces Target Price $450
HCA Healthcare: Buy Rating Driven by Projected EBITDA Growth and State Directed Payments Impact
Mizuho Securities Adjusts Price Target on HCA Healthcare to $425 From $385
HCA Healthcare Analyst Ratings
Deutsche Bank Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $441
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $392 Price Target
HCA Healthcare Analyst Ratings
Deutsche Bank Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $441
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Maintains Target Price $427
HCA Healthcare: Hold Rating Amidst Florida Market Challenges and Expansion Investments
Deutsche Bank Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $441
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
DBS Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $447
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and HCA Healthcare (HCA)
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Maintains Target Price $427
BofA Securities Initiates HCA Healthcare(HCA.US) With Buy Rating
HCA Healthcare (HCA) Gets a Buy From Bank of America Securities
Jefferies Maintains HCA Healthcare(HCA.US) With Buy Rating, Raises Target Price to $455
Jefferies Sticks to Their Buy Rating for HCA Healthcare (HCA)
Morgan Stanley Initiates HCA Healthcare(HCA.US) With Hold Rating, Announces Target Price $427